International Congress Munich 2014

Saturday, 06.09.2014 Sunday, 07.09.2014 Monday, 08.09.2014 Tuesday, 09.09.2014 Wednesday, 10.09.2014		Sponsored symposia: Boehringer Ingelheim Evening Symposium: "Identifying the unmet needs in asthma: Who, why and how many?" Bayer Expert Forum: “Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in Non-CF Bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.

Update on lung cancer biology for clinicians

Symposium
Chairs: P. Schnabel (Meckesheim, Germany), S. Spiro (Middlesex, United Kingdom)
Aims: The audience will get an update on the current developments of targeted therapy of lung cancer, the importance of molecular pathology for optimising tumour differentiation and therapy selection, and the challenges involved in useing newly developed strategies.

Download all media

EGFR-inhibition: resistance mechanisms and new strategies A. Cortot (Lille, France)
ALK- and ROS-1-inhibition: a relevant treatment strategy for lung cancer? L. Paz-Ares (Sevilla, Spain)
Advances in targeted therapy: the clinicians point of view R.M. Huber (Munich, Germany)